Clinical trials: Noninvasive Plaque Characterization
Coronary Artery Disease, Atherosclerosis
CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)
This study evaluates the use of CaRi-Heart® analysis, an artificial-intelligence (AI) software tool that measures inflammation in the coronary arteries using images already captured during a standard Coronary CT Angiography…
- Conditions
- Coronary Artery Disease, Atherosclerosis, Cardiovascular Inflammation
- Trial name
- CARE-CCTA (NCT07220304)
- Testing
- CaRi-Heart® Analysis
- Where
- 18 sites in United States
- Volunteers
- 15,000 people
- Sponsor
- Corazon Medical PC
Coronary Artery Disease, Noninvasive Plaque Characterization
CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes
To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery…
- Trial name
- NCT02030704
- Where
- 2 sites in Germany, Hungary
- Volunteers
- 300 people
- Sponsor
- University Hospital Heidelberg